We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

40 hedge funds and large institutions have $1.99M invested in Cognition Therapeutics in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

2.66% less ownership

Funds ownership: 13.26% → 10.6% (-2.7%)

13% less funds holding

Funds holding: 46 → 40 (-6)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

77% less capital invested

Capital invested by funds: $8.82M → $1.99M (-$6.82M)

Holders
40
Holders Change
-6
Holders Change %
-13.04%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
5
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$204K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$145K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$97.9K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$81.3K
5
VF
Virtu Financial
New York
+$59K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$1.08M
2
TIM
Timelo Investment Management
Ontario, Canada
-$600K
3
ACM
AIGH Capital Management
Maryland
-$499K
4
CC
Carlson Capital
Texas
-$232K
5
CCM
Corsair Capital Management
New York
-$129K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$583K +$97.9K +95,000 +8%
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$234K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$152K +$81.3K +78,876 +32%
CM
4
CM Management
Florida
$117K +$51.5K +50,000 +25%
AFG
5
American Financial Group
Ohio
$96K – – –
UBS Group
6
UBS Group
Switzerland
$92.8K +$204K +197,859 New
SPC
7
Sigma Planning Corp
Michigan
$92.4K +$25.8K +25,050 +15%
KAS
8
Kestra Advisory Services
Texas
$88.3K – – –
BlackRock
9
BlackRock
New York
$72.9K +$3.06K +2,964 +2%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$64K +$145K +140,943 New
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$42K – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$41.6K -$1.05K -1,018 -1%
BCM
13
Bridgeway Capital Management
Texas
$35.9K – – –
State Street
14
State Street
Massachusetts
$29.4K – – –
VF
15
Virtu Financial
New York
$27K +$59K +57,231 New
TCBWMS
16
Texas Capital Bank Wealth Management Services
Texas
$26K – – –
FC
17
FCA Corp
Texas
$24.1K – – –
CWM
18
Circle Wealth Management
New Jersey
$22.9K – – –
Northern Trust
19
Northern Trust
Illinois
$22.3K – – –
CWM
20
Castle Wealth Management
Florida
$20.3K – – –
BSB
21
Bangor Savings Bank
Maine
$15.9K – – –
NFC
22
Northeast Financial Consultants
Connecticut
$11.5K – – –
TAM
23
Tocqueville Asset Management
New York
$11K -$17K -16,500 -41%
HighTower Advisors
24
HighTower Advisors
Illinois
$11K – – –
Jane Street
25
Jane Street
New York
$10.7K +$23.4K +22,730 New
1
2 3

CGTX Hedge Fund Activity: Q3 2024 in Review

40 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q3 2024, worth a combined $1.99M — down 77% from $8.82M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CGTX and 9 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was UBS Group, opening a new position worth an estimated $204K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.08M sold.

  • 40 institutional investors held Cognition Therapeutics (CGTX) as of Q3 2024, down from 46 in Q2 2024.
  • Funds reported $1.99M of Cognition Therapeutics stock for Q3 2024, down 77% quarter-over-quarter.
  • 9 funds opened new Cognition Therapeutics positions in Q3 2024 and 14 closed out, a net change of -5 holders.
  • The largest Cognition Therapeutics buyer in Q3 2024 was UBS Group, an estimated $204K added.
  • The largest Cognition Therapeutics seller in Q3 2024 was AWM Investment Company, an estimated $1.08M sold.

Based on aggregated 13F filings for Q3 2024.